Literature DB >> 18088176

Globin gene enhancer activity of a DNase-I hypersensitive site-40 homolog in medaka, Oryzias latipes.

Kouichi Maruyama1, Yuji Ishikawa, Shigeki Yasumasu, Ichiro Iuchi.   

Abstract

In medaka, we found a C16orf35-like gene in the region within 1 Kbp 3' downstream of the psibeta end of the 36-Kbp embryonic globin gene cluster ((5')alpha0(3')-(3')beta1(5')-(5')alpha1(3')-(5')beta2(3')-(5')alpha2(3')-(3')alpha3(5')-(5')beta3(3')-(3')beta4(5')-(5')alpha4(3')-(3')psialpha(5')-(5')psibeta(3')). Intron 5 of the gene contained a region having NF-E2 binding sites located between GATA boxes. The region was homologous to human HS-40 in terms of the existence and structure of characteristic transcription-factor binding sites and was named Ol-HS-40. Injection of the fusion gene construct Ol-HS-40-alpha0(up-2)GFP, consisting of Ol-HS-40, a 5' upstream 200-bp minimum promoter for alpha0, and green fluorescent protein (GFP), showed that Ol-HS-40, as in human HS-40, had the ability to strongly enhance GFP expression in erythroid cells of embryos. Further analysis using transgenic technology revealed that Ol-HS-40 had the ability to change the type of the GFP expression from embryo-to-young fish to embryo-to-adult. In addition, the results suggest that Ol-HS-40, although its natural function remains unclear, has strong enhancer activity for the expression of not only the alpha-globin gene but also the beta-globin gene.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18088176     DOI: 10.2108/zsj.24.997

Source DB:  PubMed          Journal:  Zoolog Sci        ISSN: 0289-0003            Impact factor:   0.931


  1 in total

1.  Zebrafish globin switching occurs in two developmental stages and is controlled by the LCR.

Authors:  Jared J Ganis; Nelson Hsia; Eirini Trompouki; Jill L O de Jong; Anthony DiBiase; Janelle S Lambert; Zhiying Jia; Peter J Sabo; Molly Weaver; Richard Sandstrom; John A Stamatoyannopoulos; Yi Zhou; Leonard I Zon
Journal:  Dev Biol       Date:  2012-04-19       Impact factor: 3.582

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.